DailyDoctor Archive Specialties Get app
Back to the 15 October 2026 edition

Research · 03 of 05

Personalised psychotherapy for IBS was feasible, but personalising made no clear difference

Offer gut-directed hypnotherapy or CBT for refractory IBS; there is no evidence yet that personalising the choice helps.

Design
Pilot randomised controlled trial, three arms
Population
79 adults with IBS and high symptom burden
Primary outcome
Feasibility of personalised allocation
Effect
73.4% completed therapy; no difference between personalised and mismatched allocation

PIONEER-IBS was a pilot randomised trial of 79 patients with IBS and high symptom burden (IBS-SSS around 314). After seven weeks of daily symptom diaries, patients were assigned either eye movement desensitisation and reprocessing or gut-directed hypnotherapy — matched to their symptom pattern, deliberately mismatched, or given optimised usual care.

The primary outcome was feasibility: 73.4% completed at least five of seven sessions. Somatic symptom burden improved within both therapy groups after treatment, but outcomes did not differ between personalised and mismatched allocation at the end of treatment or three months later.

Gut-directed hypnotherapy already has trial evidence in IBS. This pilot does not show that tailoring the choice of therapy to symptom diaries adds anything, and it was not designed to test efficacy.

  • Offer a brain-gut psychological therapy, such as gut-directed hypnotherapy or CBT, for refractory IBS
  • Explain the brain-gut model to patients before referral to improve uptake
  • Do not delay therapy for symptom diaries aimed at matching a therapy type
  • Continue diet and drug measures alongside psychological treatment

Why it matters

It tempers enthusiasm for personalising IBS therapy before simpler, proven options are used.

Don't overread it

This was a feasibility pilot; within-group improvements cannot show that either therapy works better than usual care.

The statistics, in plain English

Within-group improvement compares patients with themselves before and after, which also captures natural improvement and placebo effects. Only between-group comparisons test the therapy, and those showed no difference.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

cirrhosismasldendoscopyfunctional

Tomorrow morning, before your first patient

One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app